Johnson and Johnson
Johnson and Johnson's brand identity communicates the company's bold healthcare innovation while staying true to its global patient care.
Leveraging advanced medicine and technology, the company proactively tackles complex diseases with more innovative, less invasive, and personalized solutions.
The company plans to gradually implement the new logo, colors, and font across all its materials, product packaging, and branding assets.
is currently revitalizing its brand and consolidating its MedTech and pharmaceutical segments under the unified name of Johnson and Johnson, demonstrating a steadfast commitment to healthcare innovation and addressing the most challenging health issues.
The announcement signifies a pivotal moment in Johnson and Johnson's evolution as the company harnesses its extensive knowledge of innovative medicine and cutting-edge medical technology. This strategic move aims to proactively address, treat, and ultimately find cures for intricate diseases while simultaneously ushering in solutions characterized by heightened intelligence, reduced invasiveness, and greater personalization, marking a significant stride toward reshaping the future of healthcare.
The company's two major segments will become more closely associated with the Johnson and Johnson brand. Over time, Janssen, the company's pharmaceutical part, will assume the name Johnson and Johnson Innovative Medicine, while the medical technology segment will retain the Johnson and Johnson MedTech designation.
The pharmaceuticals segment leads the way in advancing healthcare, pioneering treatments to reshape the future of well-being. Johnson and Johnson Innovative Medicine combines a compassionate scientific approach to effectively confront the most complex diseases in oncology, immunology, neuroscience, cardiovascular, pulmonary hypertension, and retina to develop future medications. Simultaneously, the medical technology segment dedicates itself to addressing the most pressing healthcare challenges through innovations at the nexus of biology and technology.
Vanessa Broadhurst, Executive Vice President of Global Corporate Affairs, stated,
Our Johnson and Johnson brand identity communicates our bold approach to innovation in healthcare while staying true to the care we have for our patients around the world.
[Source: Business Wire]
The updated Johnson and Johnson
logo, featuring letters drawn in a single stroke for added contrast and a sense of unexpectedness, embraces both long and short versions, with the 'J&J' abbreviation gaining prominence, especially in digital contexts. The color palette leans toward a refreshed and contemporary red, symbolizing the company's agility in responding to health challenges and evolving with the times. The revamped ampersand now signifies global recognition, openness, and the connections that breathe life into the brand's purpose. In terms of art direction, elements such as illustration and photography have undergone careful curation to evoke energy, optimism, and inclusivity, presenting a distinctive approach within the healthcare domain.